Marriott Vacations Worldwide Corporation Stock 12‑Month Price Target Raised to $115.09, Implies 4% Downside
Marriott Vacations Worldwide's (VAC) average price target increased to $115.09 from $113.91, with estimates ranging from $65 to $147. This implies a 4% downside from the Aug. 17 closing price. The consensus rating remains 'Buy' among 13 analysts, with 7 Buys, 2 Holds, and 4 Sells, according to FactSet.
How this was made
The 30-second read
Why it matters
The only actionable content is the updated consensus target level and the implied upside/downside versus the Aug. 17 closing price; it does not include new earnings, guidance, or operational developments.
Market read
Consensus target moved up slightly, but the implied downside from the latest close suggests the market may still view valuation or expectations as ahead of fundamentals.
What to watch
The article does not disclose which analysts changed their views or the underlying thesis, so traders cannot infer a specific fundamental driver.
Background
The piece summarizes FactSet-based consensus analyst estimates for Marriott Vacations Worldwide’s 12-month price target and rating mix.
Ticker impact
Marriott Vacations Worldwide’s average 12-month price target rose from $113.91 to $115.09, implying about 4% downside from the Aug. 17 close.
Limited, likely sentiment-driven drift rather than a major repricing unless additional upgrades or earnings catalysts follow.
The article is purely a consensus price-target update, with no new fundamentals, guidance, or company-specific event beyond the target revision.
Market effects
Small read-through for travel/leisure analyst sentiment, but no sector-wide catalyst is provided.
No regional macro or demand signal is included.
No global event or cross-border driver is mentioned.
Counterpoint
A higher consensus target can still coincide with bearish positioning if the market already priced in the improvement, leaving downside from the current close.
Key entities
- companyMarriott Vacations Worldwide Corporation
Subject of the article, with consensus 12-month price target raised to $115.09 and rating mix remaining Buy.
